• Michel Kuehn and Dr. Raymund Heinen set to retire
• Stefan Grote appointed as Board Member for Incontinence Management
Heidenheim, Germany - February 24, 2021 – The HARTMANN GROUP today announced changes to its Management Board. Michel Kuehn, responsible for Incontinence Management, and Dr. Raymund Heinen, Chief Process Officer, will retire over the course of the year. Stefan Grote will join Paul HARTMANN AG as a new member of the Management Board responsible for Incontinence Management on April 1, 2021.
Michel Kuehn looks back on a total of 28 successful years at HARTMANN, since 2006 as a member of the Management Board with responsibility for sales and most recently the Incontinence business. In addition, he managed HARTMANN's business in France. He will hand over his seat on the Management Board on March 31, 2021, and his management position in France on June 30, 2021.
Over the past six years, Dr. Raymund Heinen has been responsible for the globalization of the Production, Procurement, Quality, Regulatory Affairs, IT and Real Estate Management functions, some subsidiaries and the modernization of core processes in the company. He also drove the implementation of the Medical Device Regulation (MDR). He will retire on September 30, 2021.
"With Michel Kuehn and Dr. Raymund Heinen, two long-standing HARTMANN leaders are retiring who have strongly shaped the company in their respective areas of responsibility and have successfully contributed to the company's direction and development. The company owes them a great deal. We wish them good luck and, above all, good health for this period of their lives ahead of them," explains Fritz-Juergen Heckmann, Chairman of the Supervisory Board of the HARTMANN GROUP.
Michel Kuehn looks back on a total of 28 successful years at HARTMANN, since 2006 as a member of the Management Board with responsibility for sales and most recently the Incontinence business. In addition, he managed HARTMANN's business in France. He will hand over his seat on the Management Board on March 31, 2021, and his management position in France on June 30, 2021.
Over the past six years, Dr. Raymund Heinen has been responsible for the globalization of the Production, Procurement, Quality, Regulatory Affairs, IT and Real Estate Management functions, some subsidiaries and the modernization of core processes in the company. He also drove the implementation of the Medical Device Regulation (MDR). He will retire on September 30, 2021.
"With Michel Kuehn and Dr. Raymund Heinen, two long-standing HARTMANN leaders are retiring who have strongly shaped the company in their respective areas of responsibility and have successfully contributed to the company's direction and development. The company owes them a great deal. We wish them good luck and, above all, good health for this period of their lives ahead of them," explains Fritz-Juergen Heckmann, Chairman of the Supervisory Board of the HARTMANN GROUP.
Stefan Grote will take over Incontinence Management as of April 1, 2021. He is currently a member of the Group Management of Constantia Flexibles, one of the world's leading manufacturers of flexible packaging for the food and pharmaceutical industries. He brings extensive experience from the consumer goods industry, brand management, production and in the implementation of transformation programs.
"With Stefan Grote, HARTMANN gains a highly experienced Management Board member who knows both the B2B business and the consumer business in all its facets and has proven his leadership qualities in a wide variety of areas of responsibility," says Heckmann. "With his experience, he will help to ensure that HARTMANN's transformation program continues to be successfully implemented. We are very much looking forward to working with him."
HARTMANN is thus reducing its Management Board from five to four members. In addition to Stefan Grote, the Management Board will continue to include Britta Fuenfstueck, CEO, Stefan Mueller, CFO, and Francois Georgelin, Wound Management.
"With Stefan Grote, HARTMANN gains a highly experienced Management Board member who knows both the B2B business and the consumer business in all its facets and has proven his leadership qualities in a wide variety of areas of responsibility," says Heckmann. "With his experience, he will help to ensure that HARTMANN's transformation program continues to be successfully implemented. We are very much looking forward to working with him."
HARTMANN is thus reducing its Management Board from five to four members. In addition to Stefan Grote, the Management Board will continue to include Britta Fuenfstueck, CEO, Stefan Mueller, CFO, and Francois Georgelin, Wound Management.
